SciELO - Scientific Electronic Library Online

 
vol.128 número12Uso precoz de la eritropoyetina en la prevención de la anemia del prematuroFactores de riesgo tromboembólico en el flutter auricular.: Estudio con ecocardiografía transesofágica índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

PRADO J, Valeria et al. In vitro activity of moxifloxacin and other antimicrobials against respiratory pathogens. Rev. méd. Chile [online]. 2000, vol.128, n.12, pp.1319-1326. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872000001200003.

Background: Respiratory pathogens are becoming increasingly resistant to antimicrobials. A new group of drugs, called respiratory quinolones have been synthesized to overcome this problem. Aim: To study the in vitro susceptibility of respiratory pathogens to old and new antimicrobials. Material and methods: Forty five strains of S pneumoniae, 44 strains of H influenzae, 21 strains of M catarrhalis, 10 strains of methicillin susceptible S aureus and 20 strains of methicillin resistant S aureus were studied. All were isolated from community acquired respiratory infections during 1999. Minimal inhibitory concentrations of moxifloxacin, amoxicilin, amoxicilin/clavulanic acid, clarithromycin, azithromycin, ciprofloxacin and levofloxacin were determined using the Etest method. Betalactamase production by H influenzae and M catarrhalis was also studied. Results: S pneumoniae strains were 100% susceptible to quinolones and cotrimoxazole, 2% were resistant to macrolides, 11% were resistant to amoxicilin/clavulanic acid and 47% were resistant to cefuroxime. H influenzae was 100% susceptible to quinolones, azithromycin and amoxicilin/clavulanic acid. There was a 53% resistance to cotrimoxazole, 21% to amoxicilin, 9% to clarithromycin and 7% to cefuroxime. M catarrhalis was 100% susceptible to quinolones and 100% resistant to amoxicilin, 5% resistant to macrolides, 14% resistant to amoxicilin/clavulanic acid, 20% to cefuroxime and 30% to cotrimoxazole. Methicilline susceptible S aureus was susceptible to all antimicrobials and methicillin resistant S aureus was resistant to all. Conclusions: Moxifloxacin and the new respiratory quinolones can be useful in the treatment of respiratory infections (Rev Méd Chile 2000; 128: 1319-26).

Palavras-chave : Anti-Infective Agents; Quinolones; Respiratory Tract Infections.

        · texto em Espanhol

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons